These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice. Joshi AU; Orset C; Engelhardt B; Baumgart-Vogt E; Gerriets T; Vivien D; Kanse SM Eur J Neurosci; 2015 Apr; 41(7):965-75. PubMed ID: 25615590 [TBL] [Abstract][Full Text] [Related]
4. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP. Stephan S; Schwarz H; Borchert A; Bussfeld D; Quak E; Simshaeuser-Knaub B; Teigelkamp S; Behrens F; Vitzthum F Clin Chem Lab Med; 2008; 46(8):1109-16. PubMed ID: 18605956 [TBL] [Abstract][Full Text] [Related]
8. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531 [TBL] [Abstract][Full Text] [Related]
10. No evidence for an association between ABO blood group and overall ischemic stroke or any of the major etiologic subtypes. Hanson E; Karlsson S; Jood K; Nilsson S; Blomstrand C; Jern C Thromb Res; 2012 Sep; 130(3):339-42. PubMed ID: 22482829 [TBL] [Abstract][Full Text] [Related]
11. Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models. Kim JY; Manna D; Etscheid M; Leergaard TB; Kanse SM FASEB J; 2022 Oct; 36(10):e22564. PubMed ID: 36165219 [TBL] [Abstract][Full Text] [Related]
12. Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome. Parahuleva MS; Hölschermann H; Zandt D; Pons-Kühnemann J; Parviz B; Weiskirchen R; Staubitz A; Tillmanns H; Erdogan A; Kanse SM Circ J; 2012; 76(11):2653-61. PubMed ID: 22850287 [TBL] [Abstract][Full Text] [Related]
13. Factor VII activating protease. Single nucleotide polymorphisms light the way. Kanse SM; Etscheid M Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671 [TBL] [Abstract][Full Text] [Related]
14. Expression of the Marburg I Single Nucleotide Polymorphism (MI-SNP) and the Marburg II Single Nucleotide Polymorphism (MII-SNP) of the Factor VII-Activating Protease (FSAP) Gene and Risk of Coronary Artery Disease (CAD): A Pilot Study in a Single Population. Parahuleva MS; Schieffer B; Klassen M; Worsch M; Parviz B; Hölschermann H Med Sci Monit; 2018 Jun; 24():4271-4278. PubMed ID: 29927903 [TBL] [Abstract][Full Text] [Related]
19. The G534E-polymorphism of the gene encoding the factor VII-activating protease is a risk factor for venous thrombosis and recurrent events. Ahmad-Nejad P; Dempfle CE; Weiss C; Bugert P; Borggrefe M; Neumaier M Thromb Res; 2012 Sep; 130(3):441-4. PubMed ID: 22421107 [TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients. Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]